van Zandwijk N, McVie J G, Dalesio O, Kirkpatrick A
Eur J Respir Dis Suppl. 1987;149:57-62.
An overview of activities of the EORTC Lung Cancer Coöperative Group in small cell lung cancer is given. Optimal length of therapy, identification of patients with good/bad prognostic factors, role of surgery and the study of new drugs presently are the main areas of interest for the group. With its large patient potential the group is able to verify "early favourable reports" and to quickly perform phase II studies.
本文概述了欧洲癌症研究与治疗组织（EORTC）肺癌合作组在小细胞肺癌方面的活动。治疗的最佳时长、具有良好/不良预后因素患者的识别、手术的作用以及目前新药的研究是该合作组主要关注的领域。凭借其庞大的患者群体，该合作组能够验证“早期有利报告”并迅速开展II期研究。
